Live Breaking News & Updates on Ionis Pharmaceuticals Trading
Stay updated with breaking news from Ionis pharmaceuticals trading. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) have received a consensus recommendation of “Hold” from the nine research firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to […] ....
Allene M. Diaz Sells 657 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) was the target of a large growth in short interest in June. As of June 15th, there was short interest totalling 8,690,000 shares, a growth of 33.3% from the May 31st total of 6,520,000 shares. Based on an average daily trading volume, of 1,210,000 shares, the days-to-cover ratio […] ....
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) have been given a consensus rating of “Hold” by the fourteen research firms that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, four have given a hold recommendation and five have assigned a buy recommendation to the […] ....
Citigroup upgraded shares of Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) from a sell rating to a neutral rating in a research report released on Thursday morning, The Fly reports. The firm currently has $36.00 price objective on the stock, up from their previous price objective of $30.00. A number of other brokerages also recently weighed […] ....